30 results
8-K
EX-1.1
HEPA
Hepion Pharmaceuticals Inc
17 Feb 21
Hepion Pharmaceuticals, Inc. Announces Proposed Public Offering of Common Stock
8:06am
of such prospectus.
“Applicable Time” means 6:15 a.m., Eastern time, on the date of this Agreement.
“Disclosure Package” means the Preliminary … notification that the Exchange is contemplating terminating such listing except as described in the Registration Statement, the Disclosure Package
424B5
HEPA
Hepion Pharmaceuticals Inc
16 Feb 21
Prospectus supplement for primary offering
5:11pm
and discuss the data generated for TXL to date, as well as the data package that would be required for the filing of an NDA and successful registration
424B5
HEPA
Hepion Pharmaceuticals Inc
16 Feb 21
Prospectus supplement for primary offering
6:03am
, to review and discuss the data generated for TXL to date, as well as the data package that would be required for the filing of an NDA and successful
8-K
EX-1.1
HEPA
Hepion Pharmaceuticals Inc
27 Nov 20
Hepion Pharmaceuticals Prices Public Offering
1:48pm
. As used herein, the terms “Registration Statement,” “ Preliminary Prospectus,” “Pricing Prospectus,” “Pricing Disclosure Package” and “Prospectus … Writing Prospectus.
“Pricing Disclosure Package” means any Issuer General Use Free Writing Prospectus issued at or prior to the Applicable Time
424B5
nb4ry1a8ucq9d 6p4
26 Mar 20
Prospectus supplement for primary offering
9:33pm
424B5
t099rcbb40
12 Feb 20
Prospectus supplement for primary offering
9:05am
424B4
7pdj5zyu3
15 Jun 18
Prospectus supplement with pricing info
12:26pm
FWP
qi85wwieq70xbqp7mu6
5 Jun 18
Free writing prospectus
4:31pm